PMID: 9640488Jun 26, 1998Paper

Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia

The Annals of Pharmacotherapy
J G WagnerW A Hening

Abstract

To review the epidemiology, etiology, and classification of insomnia and provide an overview of the pharmacologic therapy of insomnia. Novel nonbenzodiazepine hypnotics including zolpidem, zopiclone, and zaleplon, as well as nonprescription products such as valerian and melatonin, are reviewed in detail. A MEDLINE search was performed to identify relevant clinical studies, case reports, abstracts, and review articles published between April 1992 and December 1997. Key search terms included insomnia, benzodiazepines, zolpidem, zopiclone, zaleplon, Cl 284,846, melatonin, and valerian. Additional references were obtained from the lists of review articles and textbooks. Data concerning the safety and efficacy of the hypnotic agents were extracted from all available clinical trials and abstracts. Background information regarding insomnia, benzodiazepines, and other hypnotics was extracted from the most current literature, including review articles and textbooks. New developments in benzodiazepine receptor pharmacology have introduced novel nonbenzodiazepine hypnotics that provide comparable efficacy to benzodiazepines. Although they may possess theoretical advantages over benzodiazepines based on their unique pharmacologic profiles,...Continue Reading

References

Oct 1, 1976·The American Journal of Psychiatry·J S CarmanF K Goodwin
Oct 1, 1992·Chronobiology International·A J LewyR L Sack
Oct 15, 1992·Biological Psychiatry·B ClaustratG Chazot
Apr 1, 1992·Journal of Pineal Research·O TzischinskyP Lavie
Jan 1, 1992·Psychopharmacology·M Lader
May 1, 1991·The Journal of International Medical Research·D SchlichH J Kryrein
May 11, 1991·Lancet·M DahlitzJ D Parkes
Jul 1, 1991·Pharmacopsychiatry·K ArankoA M Seppäläinen
Jan 25, 1990·The New England Journal of Medicine·J C Gillin, W F Byerley
Jan 1, 1990·Psychopharmacology·F WaldhauserI Trinchard-Lugan
Nov 4, 1989·BMJ : British Medical Journal·F B MacGregorP C Hayes
Jan 1, 1989·European Journal of Clinical Pharmacology·J M Monti
Apr 1, 1989·Pharmacology, Biochemistry, and Behavior·O Lindahl, L Lindwall
Jan 1, 1989·European Journal of Clinical Pharmacology·E van der Kleijn
Nov 1, 1985·The Medical Clinics of North America·T RothW Conway
Feb 1, 1988·Journal of Ethnopharmacology·P J Houghton
Dec 1, 1987·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S P JamesT A Wehr
Jan 1, 1985·Psychopharmacology·G Balderer, A A Borbély
Apr 1, 1985·Planta medica·P D Leathwood, F Chauffard
Jan 1, 1983·Pharmacology·C B PullJ P Brun
Oct 1, 1984·Neuroendocrinology·F WaldhauserR J Wurtman
Jul 1, 1982·Pharmacology, Biochemistry, and Behavior·P D LeathwoodR Munoz-Box
Jan 1, 1995·European Journal of Clinical Pharmacology·N J WesenstenG L Belenky
Jan 1, 1993·Drugs·M Maczaj
Feb 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·L B Weekley
May 1, 1995·Clinical Pharmacology and Therapeutics·I V ZhdanovaD L Schomer
Mar 6, 1995·European Journal of Pharmacology·R NaveP Lavie
Dec 14, 1994·JAMA : the Journal of the American Medical Association·C A Gericke, A C Ludolph
Jul 1, 1994·The American Journal of Psychiatry·A A NierenbergM Rosenthal
Aug 7, 1993·Lancet·R CavallaroE Smeraldi

❮ Previous
Next ❯

Citations

Dec 10, 2014·Pharmaceutical Patent Analyst·John A Christopher
Aug 11, 2012·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Dong-Yoon KangByung-Joo Park
Apr 5, 2001·Current Rheumatology Reports·L J Crofford, B E Appleton
Nov 6, 2009·Journal of the American Chemical Society·Jacqueline D HicksStephen L Buchwald
Feb 15, 2002·Journal of the American Geriatrics Society·P S WangJ Avorn
Dec 6, 2001·Current Treatment Options in Neurology·Vani Rao, Pamela Rollings
Dec 21, 2000·Current Treatment Options in Neurology·C M MorinM C Ouellet
Dec 26, 2001·The New England Journal of Medicine·D P White
Sep 2, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Liqin Jiang
Sep 17, 2013·Expert Opinion on Drug Safety·Enrico Smeraldi, Dario Delmonte
Jan 7, 2004·Journal of Toxicology. Clinical Toxicology·David M ReithMurray Tilyard
Oct 9, 2012·Child and Adolescent Psychiatric Clinics of North America·Rafael Pelayo, Kin Yuen
Apr 15, 2011·Sleep Medicine·Diana M Taibi, Michael V Vitiello
Feb 2, 2011·Pediatric Clinics of North America·Bantu ChhanganiCynthia Feucht
Feb 2, 2011·Pediatric Clinics of North America·Cynthia Feucht, Dilip R Patel
Mar 23, 2010·Chemico-biological Interactions·María Eugenia LetelierFelipe Aguilera
Jun 17, 2008·Seminars in Pediatric Neurology·Rafael Pelayo, Michael Dubik
May 8, 2007·Emergency Medicine Clinics of North America·Laura K Bechtel, Christopher P Holstege
Jun 7, 2005·Journal of the American Geriatrics Society·Sebastian Schneeweiss, Philip S Wang
Aug 26, 2009·Geriatrics & Gerontology International·Arne Fetveit
Sep 17, 2009·Journal of Clinical Pharmacy and Therapeutics·L-C ChenC-H Shao
May 28, 2011·Biomedical Chromatography : BMC·Kishore Kumar HothaV Venkateswarulu
May 23, 2013·British Journal of Pharmacology·R MouldC J Langmead
Jul 25, 2006·The American Journal of Geriatric Pharmacotherapy·Kevin T Bain
May 4, 2004·Gastrointestinal Endoscopy Clinics of North America·Ed Horn, Suzanne Amato Nesbit
Mar 11, 2004·Pediatric Clinics of North America·Rafael PelayoChristian Guilleminault
Jun 15, 2015·Seminars in Pediatric Neurology·Matthew M Troester, Rafael Pelayo
Mar 4, 2008·Respiratory Medicine·Gerben StegeYvonne F Heijdra
Jun 21, 2011·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Nita Chainani-WuSol Silverman
Mar 26, 2004·Health and Quality of Life Outcomes·Luciana FrighettoPeter Jewesson
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Lodewijk van den Meerschaut, Andrea Sünder
Jun 10, 2015·Sleep Medicine Clinics·Philip M Becker, Manya Somiah
Jul 15, 2004·Oncology Nursing Forum·Muriel J Montbriand
Feb 18, 2004·The Annals of Pharmacotherapy·Leonard R RappaMargaretta L Kearson
Mar 31, 2017·International Journal of Clinical Pharmacy·Pitchaya DilokpattanamongkolChuthamanee Suthisisang
Mar 27, 2002·The Psychiatric Clinics of North America·Catherine C Crone, Geoffrey Gabriel
Sep 3, 2004·The Journal of ECT·Kunal K Patra, C Edward Coffey
Nov 13, 2004·Journal of Clinical Psychopharmacology·Sebastian Schneeweiss, Philip S Wang
May 29, 2004·Integrative Cancer Therapies·Keith I BlockMark N Mead
Oct 31, 2002·Human Psychopharmacology·Alain PatatIan Hindmarch
Sep 23, 2003·The Nurse Practitioner·Heathereen Cochran
Oct 22, 2013·The American Journal of Hospice & Palliative Care·Raghava R Induru, Declan Walsh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.